What is Screen Inc?
Screen Inc. specializes in delivering precise, cost-effective, and non-invasive cognitive testing solutions designed to identify the earliest indicators of cognitive decline, such as Mild Cognitive Impairment (MCI) and dementia. Their core offering, the CANS-MCI Test Battery, empowers physicians with an objective tool for patient cognitive health evaluation, benefiting from full reimbursement via Medicare and major insurance carriers. The company primarily serves healthcare providers seeking to enhance their diagnostic capabilities with reliable cognitive assessments that minimize clinician resource demands. Screen Inc. emphasizes a user-friendly, multilingual testing process, allowing for patient self-administration post-setup, thereby ensuring a comfortable and stress-free experience.
How much funding has Screen Inc raised?
Screen Inc has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
What's next for Screen Inc?
As Screen Inc. operates within the Series A/B growth stage, the recent capital injection is expected to fuel strategic expansion. This likely involves scaling their market penetration among healthcare providers, potentially enhancing their CANS-MCI Test Battery with further technological advancements, and broadening their reach to address the growing global need for early cognitive decline detection. The company's focus on insurance reimbursement and physician adoption suggests a trajectory aimed at integrating their solutions seamlessly into standard healthcare practices, positioning them for significant impact in the neurodegenerative disease diagnostics sector.
See full Screen Inc company page
